Growing Pains: Early Detection and Timely Intervention for Pediatric Endocrine Disorders in Primary Care

5 (1 vote)

Supported by an educational grant from Mannkind

Pediatric type 1 diabetes can feel like an unfamiliar terrane, with what seems like exotic nuances, for many primary care clinicians. This practical, evidence-based session serves as your "survival guide" to recognizing early warning signs, interpreting diagnostic findings, understanding insulin management, navigating continuous glucose monitoring, managing illness and physical activity, and partnering with families, schools, and pediatric endocrinology. Using current ADA, AACE, and ISPAD recommendations and real-world scenarios, clinicians will gain confidence in working with endocrinology in caring for children with T1DM from initial presentation in primary care, urgent care, or the emergency room to sick day management, sports participation, school, activities, refills and beyond.

*Due to rapidly changing clinical knowledge, once purchased, you have 90 days access to complete this education.

Credits: 1.5 Contact Hours; 1.0 are Pharmacology
This activity is designated for 1.5 AAPA Category 1 CME credits. Approval is valid from 9/23/2026 to 12/22/2026 . PAs should only claim credit commensurate with the extent of their participation.
Expiration Date: September 30, 2027

FREE

LEARNING OBJECTIVES

After taking part in this educational activity, participants should be better able to:

Review the epidemiology, pathophysiology, and presenting features of type 1 diabetes mellitus
Recognize early warning signs of T1DM in pediatric primary care and urgent care settings and identify when urgent evaluation or escalation is warranted
Interpret key diagnostic findings indicative of diagnosis and ongoing monitoring of patients with T1DM.
Identify major principles of insulin dosing, including oral insulin options, and adjustment in pediatric T1DM patients related to daily management, illness, and sports or activity.
Apply practical, evidence-based approaches to quality of life for patient and family, including patient/family counseling, sick-day considerations, and reinforcement of safe self-management strategies
Strengthen coordination of care with pediatric endocrinology, caregivers, schools, and school nurses to support continuity and safety

Terri Schmitt

Executive Director, PhD, APRN, FNP-BC, FAANP

NPACE

Dr. Terri Schmitt is a Family Nurse Practitioner, educator, and diabetes specialist with more than 25 years of clinical experience in advanced practice across family, pediatrics, endocrinology, and chronic disease management. As Executive Director of NPACE, she leads national continuing education initiatives and brings a strong focus on evidence based care, clinical quality, and practical, applicable learning for advanced practice clinicians. In her clinical role with Galileo Health, she provides primary and chronic disease care with emphasis on diabetes management, patient education, and improving access for diverse populations – creating their diabetes education program and serving as consultant to other providers on complex diabetes cases. Dr. Schmitt’s academic work includes teaching and leading in one of the country’s largest FNP programs and contributing to diabetes education through research, national presentations, and curriculum development. A Fellow of the American Association of Nurse Practitioners, and a member of multiple APP organizations- she is most recognized for her 3-legged Boston Terrier with spina bifida and her love of all things John Mayer.

CE/CME INFORMATION

Obtain Your Credits

To earn credits for this activity, navigate to the Content(s) tab and complete all course components in the following order: 1) watch the course presentation video; 2) complete the course evaluation; 3) pass the post-test with a score of 2/3 (66.7%) or higher. You may retake the post-test until a passing score is achieved, at which point you will be able to view/print a copy of your certificate of completion. This online certificate will also be saved within your profile 'My Courses/Certificates' -> 'Transcript/Certificates Earned' for future access.

Designation Statement

NPACE designates this educational activity for a maximum of 1.5 contact hours, of which 1.0 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.

This activity has been reviewed by the American Academy of Physician Associates Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. Approval is valid from 9/23/2026 to 12/22/2026. PAs should only claim credit commensurate with the extent of their participation.

Accreditation Statement

Nurse Practitioner Associates for Continuing Education is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

This program is supported by an educational grant from Mannkind

DISCLOSURES

Faculty

Contributing faculty, Terri Schmitt, PhD, APRN, FNP-BC, and FAANP, have disclosed no relevant financial relationships.

Planners

All planners and contributors involved in this educational activity have disclosed no relevant financial relationships.

Disclaimer

The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.

Disclosure of Unlabeled Use

This educational activity may mention the uses of products that are not approved by the FDA for the indication(s) being discussed. The presenter(s) are instructed to notify participants when they are discussing unapproved uses or investigational agents. The opinions related to unapproved uses of products are solely those of the presenter(s) and are not endorsed or recommended by NPACE. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Commercial Support

There is no commercial support for this activity.

This program is supported by an educational grant from Mannkind

Components visible upon registration.